Biomarker prevalence study and phase I trial of afatinib in children with malignant tumours
Year: 2017
Type: article
Source: Annals of Oncology
Institutions: Rigshospitalet, Centre Oscar Lambret, Centre Léon Bérard, Institut Curie, Centre Hospitalier Sainte-Anne, Policlinico Umberto I, Sapienza University of Rome, Centre Hospitalier Universitaire de Toulouse, Hôpital des Enfants, Great Ormond Street Hospital, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, University of Birmingham, Royal Manchester Children's Hospital, Vall d'Hebron Hospital Universitari, Dana-Farber Cancer Institute, Fondazione IRCCS Istituto Nazionale dei Tumori, Boehringer Ingelheim (Belgium), Boehringer Ingelheim (Germany), Boehringer Ingelheim (United States), Institut Gustave Roussy, Fondation Gustave Roussy
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2761983271